Beta-Blockers and Digoxin in Atrial Fibrillation: Back to the Future

Can J Cardiol. 2023 Nov;39(11):1594-1597. doi: 10.1016/j.cjca.2023.07.013. Epub 2023 Jul 13.

Authors

Paul Dorian¹, Paul Angaran²

Affiliations

¹ Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Cardiology, St Michael's Hospital, Toronto, Ontario, Canada. Electronic address: paul.dorian@unityhealth.to.
² Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Cardiology, St Michael's Hospital, Toronto, Ontario, Canada.

PMID: 37453646
DOI: 10.1016/j.cjca.2023.07.013

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adrenergic beta-Antagonists / pharmacology
Adrenergic beta-Antagonists / therapeutic use
Anti-Arrhythmia Agents / pharmacology
Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation* / drug therapy
Digoxin* / therapeutic use
Heart Rate
Humans

Substances

Digoxin
Adrenergic beta-Antagonists
Anti-Arrhythmia Agents